FY23 revenue from operations up 16% YoY to Rs. 11,933 Crs FY23 EBITDA at Rs. 1,565 Crs. and PAT (Post NCI) at 425 Crs. Q4 FY23 revenue from operations up 20% YoY to Rs. 3,262 Crs Q4 FY23 EBITDA at Rs. 506 Crs. and PAT (Post NCI) at
Global pharma major Lupin Limited (Lupin) announced today the launch of its Satellite Laboratory in Vijayawada, Andhra Pradesh. The move is part of Lupin Diagnostics’ ongoing expansion aimed at enhancing access to high-quality testing services and increasing the diagnostics network across the country. The newly
Evercare Group (“the Group”), and Indus Health Plus today announced a new 12month exclusive partnership to provide extended care to beneficiaries of Indus Health Plus at Evercare facilities. Evercare, a healthcare service provider with facilities in India, Bangladesh, Pakistan, Kenya, and Nigeria, and Indus Health Plus,
For testing the FeNO levels of patients to help more & more patients know if they are suffering from Asthm Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients Used for simple clinical
Numen Health, India's largest Digital-First Heart Care platform today announced a partnership with Aster Hospitals to provide preventive and rehabilitative medical attention to patients from the comfort of their homes. As part of this collaboration, Numen Health platform will aid Aster Hospitals' cardiologists in remotely
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans Venus Remedies Limited, a leading research-based pharmaceutical company, has achieved another significant milestone by securing a Good Manufacturing Practices (GMP) certification from
Medica Group of Hospitals, the largest private hospital chain in Eastern India, announced today, the appointment of Dr. Nandakumar Jairam as its new Chairman, bidding adieu to Founder & Former Chairman Dr. Alok Roy. Dr. Nandakumar Jairam comes with rich and varied experience in the country’s
Fortis Hospital Mulund today inaugurated the ‘NEST’ - a new floor especially curated for mothers-to-be and newborns. This 29-bedded floor was inaugurated by Dr Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, Dr S. Narayani, Business Head - Fortis Hospitals, Maharashtra, along with mom, author &
CORE Diagnostics, a leading high-end diagnostic solutions provider, has announced its new satellite lab launch in East Delhi, Hargobind Enclave. This strategic expansion aims to broaden the company's testing capacities, ensuring enhanced accessibility to high-quality diagnostic services for healthcare providers and patients. The inauguration of the
Nine (2.48%) women out of 362 were screen positive for chromosomopathy Ground-breaking Research on Prenatal Screening for Chromosomal Anomalies Redcliffe Labs, a leading omni-channel Pan India diagnostics service provider, has come out with an comprehensive research study on prenatal screening for chromosomal anomalies. Led by Dr. Sohini